V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002533 | 250009054 | 1.7 | 88 | Palliative (P) | 2019-10-26 | 2019-11-06 | null | N | N | CARBOPLATIN + FLUOROURACIL | 101026923 |
| 250002541 | 250009056 | 1.65 | 0 | null | null | 2020-06-04 | Trial Unspecified | null | N | CARBOPLATIN + PACLITAXEL | 100870402 |
| 250000284 | 250009057 | null | null | Neo-adjuvant (N) | 2020-01-16 | 2020-01-16 | Carboplatin+Fluorouracil 4 or 5 day | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101298839 |
| 250000744 | 250009060 | 1.78 | 65.1 | Palliative (P) | null | 2022-03-14 | EVEROLIMUS | null | null | CISPLATIN + RT | 101856875 |
| 250000920 | 250009065 | 1.7 | 98 | Palliative (P) | null | 2018-11-06 | null | 02 | null | CISPLATIN | 100989360 |
| 250000974 | 250009066 | null | null | null | null | 2020-05-18 | Carboplatin + Pemetrexed | null | N | TIVOZANIB | 101827919 |
| 250001057 | 250009067 | 1.69 | 52 | null | null | 2020-04-20 | Niraparib | 02 | N | CARBOPLATIN + FLUOROURACIL | 101410777 |
| 250001131 | 250009070 | 1.88 | 19.6 | null | 2020-05-12 | 2020-06-30 | Atezolizumab | 02 | N | ATEZOLIZUMAB | 100206432 |
| 250001134 | 250009071 | null | null | Palliative (P) | 2019-01-12 | 2019-01-18 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | ATEZOLIZUMAB | 100538026 |
| 250001208 | 250009072 | 1.76 | 63.2 | Palliative (P) | 2019-08-25 | 2019-11-23 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101544258 |
| 250001358 | 250009074 | 1.68 | 50.5 | null | 2019-11-18 | 2019-11-19 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | N | CARBOPLATIN + FLUOROURACIL | 100992873 |
| 250001607 | 250009075 | 1.56 | 65 | null | 2022-03-26 | 2022-04-30 | Cisplatin + Radiotherapy | 02 | N | DOXORUBICIN | 100796180 |
| 250001632 | 250009076 | 1.83 | 78.8 | null | 2022-04-02 | 2022-04-13 | GEMCITABINE + RT | 01 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101058742 |
| 250001793 | 250009078 | 1.71 | 0 | Neo-adjuvant (N) | 2020-09-02 | 2021-09-04 | CARBOPLATIN + FLUOROURACIL | 02 | N | ENZALUTAMIDE | 100602541 |
| 250001892 | 250009080 | 1.67 | 58.4 | null | null | 2020-04-15 | null | 01 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101074705 |
| 250002275 | 250009082 | null | null | Palliative (P) | 2019-08-22 | 2019-09-12 | Cisplatin + Radiotherapy | 02 | null | DOCETAXEL | 100548739 |
| 250002352 | 250009083 | null | null | Curative (C) | null | 2020-05-11 | EW EuroEwing 2012 Arm B VDC/IE | null | N | DOCETAXEL | 100092336 |
| 250001320 | 250009084 | null | null | Palliative (P) | 2018-03-11 | 2018-03-25 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + PACLITAXEL | 100015616 |
| 250002073 | 250009085 | 1.59 | 70.8 | null | null | 2020-05-14 | null | null | null | CARBOPLATIN + PEMETREXED | 101020099 |
| 250001639 | 250009118 | 1.63 | 94 | Palliative (P) | 2019-07-01 | 2019-07-21 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101341015 |
| 250001674 | 250009119 | 1.67 | 129 | Palliative (P) | 2018-05-01 | 2019-09-17 | null | 02 | Y | CISPLATIN + GEMCITABINE | 101494040 |
| 250001695 | 250009121 | null | 63.3 | null | null | 2019-11-29 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101389877 |
| 250001786 | 250009122 | 1.75 | 95 | null | null | 2016-07-07 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 101079432 |
| 250001854 | 250009123 | 1.75 | 80.7 | null | null | 2020-03-26 | CISPLATIN + GEMCITABINE | null | null | NIVOLUMAB | 100286887 |
| 250001954 | 250009124 | 1.62 | 92.6 | null | null | 2020-02-11 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101216449 |
| 250001960 | 250009125 | 1.79 | 72.6 | null | null | 2021-01-11 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101408256 |
| 250001973 | 250009126 | 1.74 | null | Palliative (P) | 2021-04-03 | 2021-11-06 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100997981 |
| 250002005 | 250009127 | 1.67 | 90.25 | null | null | 2020-05-22 | GEMCARBO | null | null | CARBOPLATIN + GEMCITABINE | 100520456 |
| 250002078 | 250009129 | 1.55 | 56.9 | null | 2021-02-10 | 2021-02-20 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 100686510 |
| 250002083 | 250009130 | 1.78 | 52.7 | null | null | 2019-12-10 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | PEMBROLIZUMAB | 101586927 |
| 250002107 | 250009131 | 1.67 | 86.3 | null | null | 2019-07-15 | null | null | null | CARBOPLATIN + GEMCITABINE | 100626278 |
| 250002153 | 250009133 | null | 53.3 | Palliative (P) | null | 2021-12-31 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100292841 |
| 250002180 | 250009135 | null | 82.8 | null | null | 2018-09-04 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101795528 |
| 250002193 | 250009136 | 1.65 | 59.8 | null | null | 2019-02-28 | NIVOLUMAB | null | null | NIVOLUMAB | 100279828 |
| 250002254 | 250009140 | 1.61 | null | null | null | 2020-08-23 | CISPLATIN + GEMCITABINE | null | null | PEMBROLIZUMAB | 100575057 |
| 250002263 | 250009141 | 1.69 | 71.4 | Palliative (P) | 2018-02-23 | 2018-02-26 | PEMBROLIZUMAB | 02 | N | PEMBROLIZUMAB | 100975579 |
| 250002272 | 250009142 | 1.6 | 50.6 | null | null | 2020-02-28 | null | null | null | CISPLATIN + GEMCITABINE | 100196390 |
| 250002309 | 250009145 | 1.55 | null | null | null | 2019-04-26 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 101720961 |
| 250002313 | 250009146 | 1.76 | 59.1 | null | null | 2019-06-19 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | NIVOLUMAB | 101535452 |
| 250002334 | 250009149 | 1.73 | 66 | Palliative (P) | 2020-03-11 | 2020-03-12 | null | 02 | N | CARBOPLATIN + GEMCITABINE | 101637139 |
| 250002352 | 250009152 | 1.87 | 0 | null | null | 2020-05-27 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | 100092336 |
| 250002360 | 250009153 | null | null | Palliative (P) | 2020-10-18 | 2020-12-07 | null | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101227963 |
| 250002383 | 250009154 | 1.71 | 44.9 | Palliative (P) | 2020-12-18 | 2020-12-18 | null | 02 | N | CARBOPLATIN + PEMETREXED | 101814106 |
| 250002412 | 250009158 | 1.69 | 65 | null | 2018-09-01 | 2018-12-07 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101613599 |
| 250002414 | 250009159 | 1.65 | 80.5 | Curative (C) | 2020-06-02 | 2020-06-11 | Avelumab | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100241738 |
| 250002460 | 250009160 | 1.7 | 65 | Palliative (P) | 2020-08-17 | 2022-01-23 | null | 02 | N | CAPECITABINE + OXALIPLATIN | 100235580 |
| 250002487 | 250009161 | null | null | Palliative (P) | 2018-04-15 | 2018-04-24 | Cisplatin 7 day | 02 | null | FLUOROURACIL + IRINOTECAN | 100660762 |
| 250002502 | 250009163 | 1.88 | 69.25 | Palliative (P) | null | 2022-05-26 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | ENZALUTAMIDE | 100633098 |
| 250002505 | 250009165 | 1.74 | 19.6 | null | null | 2020-09-30 | Sunitinib | null | null | CARBOPLATIN + PACLITAXEL | 100572530 |
| 250002522 | 250009166 | null | null | null | null | 2022-04-09 | CARBOPLATIN + PACLITAXEL | null | null | GEFITINIB | 101018822 |